SmithKline Beecham plc v Alphapharm Pty Ltd [2001] FCA 1324
The applicants had not shown exceptional circumstances warranting reopening the earlier refusal to order provision of tablet samples. The raw material samples could be tested without limiting the applicants to particular techniques, because no such restriction had been sought at the hearing, no injustice was shown, and the applicants were entitled to check the validity of supplied test results. Access by a nominated director and patent attorneys could be allowed under undertakings, but undertakings excluding involvement in infringement proceedings outside Australia were required to quarantine confidential information because the risk of subconscious breach in relation to United States...
- Jurisdiction
- Australia
- Judgment Date
- 18 April 2001
- Procedural Posture
- Application for Preliminary Discovery in Contemplated Patent Infringement Proceedings / Determination of Outstanding Disputes as to the Form of Orders After Reasons for Orders Under O 15 a R 12 of the Federal Court Rules
- Outcome
- Orders made requiring provision of raw material samples and confidentiality protections; applicants' request for tablet samples refused; respondents' requests to limit testing, obtain indemnity costs, and avoid sample production refused.
- Legal Topics
- ['preliminary Discovery' 'provision of Samples' 'confidentiality Orders' 'undertakings' 'reopening or Rehearing' 'costs']
Case Brief
Summary, issues, holding and outcome
More case intelligence is available
Unlock the full research layer for this judgment.
Procedural Posture
Application for Preliminary Discovery in Contemplated Patent Infringement Proceedings / Determination of Outstanding Disputes as to the Form of Orders After Reasons for Orders Under O 15 a R 12 of the Federal Court Rules
Legal Issues
- 1 ['Whether the applicants should receive tablet samples as well as samples of raw material' 'Whether tests on the raw material samples should be limited to NMR, DSC and melting point analyses' "Whether access to the raw material samples should be restricted so that the applicants' patent attorneys and a nominated director could not inspect them" 'Whether the respondents should receive indemnity costs if no infringement proceeding was commenced by 1 August 2001' 'Whether recent United States infringement proceedings meant that no samples should be provided and no orders should be made under O 15A' 'Whether undertakings should quarantine confidential information from use in infringement proceedings outside Australia']
Ratio Decidendi
The applicants had not shown exceptional circumstances warranting reopening the earlier refusal to order provision of tablet samples. The raw material samples could be tested without limiting the applicants to particular techniques, because no such restriction had been sought at the hearing, no injustice was shown, and the applicants were entitled to check the validity of supplied test results. Access by a nominated director and patent attorneys could be allowed under undertakings, but undertakings excluding involvement in infringement proceedings outside Australia were required to quarantine confidential information because the risk of subconscious breach in relation to United States...
Court Disposition
Orders made requiring provision of raw material samples and confidentiality protections; applicants' request for tablet samples refused; respondents' requests to limit testing, obtain indemnity costs, and avoid sample production refused.
Orders
- ['The applicants were relieved of their undertaking dated 18 December 2000.' "The confidential annexure to the first respondent's undertaking dated 18 December 2000 was made an open record in the court file." "By 4.00pm on 27 April 2001, the first respondent was ordered to provide the applicants' solicitors a 50...
Full Case Text
Judgment text and source record
Sign in to read
Sign in to read the full judgment text
Sign in to read the full judgment text. Downloads and additional research tools may depend on your plan.
Sign in to read the full judgment